Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
Abstract Uterine corpus endometrial carcinoma (UCEC) is a significant cause of cancer-related mortality among women worldwide. Prior research has demonstrated an association between cyclin-dependent kinase inhibitor 2 A (CDKN2A) and various tumors. As a member of the INK4 family, CDKN2A is involved...
Saved in:
Main Authors: | Liang Ma, Yuling Li, Jingxian Wu, Yanfei Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-85364-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LncRNA-ANRIL regulates CDKN2A to promote malignant proliferation of Kasumi-1 cells
by: Jianxia Xu, et al.
Published: (2025-01-01) -
Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration
by: Fuda Xie, et al.
Published: (2025-01-01) -
A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma
by: Ru-Gen Liao, et al.
Published: (2025-01-01) -
Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis
by: Satoshi NAKASU, et al.
Published: (2024-12-01) -
Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma
by: Yanfang Huang, et al.
Published: (2025-01-01)